Mekong Malaria Programme

Prototype - The Containment of Artemisinin Tolerant Malaria Parasites in Southeast Asia Project

 

Key Messages

 

Publications

 

Results

 

Contact Us

 

 

 

 

 

 

 

 

Background

Partners Engaged

What We Do

Why We Do

How We Do

 

 

The battle has begun and there will be no let-up until the enemy retreats and is eventually defeated.

 

 

 

 

 

Blood test at the Cambodian border

The World Health Organisation leads the battle being waged along the Thai-Cambodian border against tolerance to artemisinin, the best available drug to treat malaria. Committed experts, partners and the Thai and Cambodian governments are engaged.

 

They persist in the fight because spread of the danger would knock back years of global efforts and imperil the world's poorest in South Asia and sub-Saharan Africa where incidence and deaths are highest, especially among children.

 

Due to increasing free access to still performing ACT and LLINs, especially in Africa, global malaria mortality is decreasing but half the world population is still at risk. China struggled with several pockets of malaria on the mainland until its own scientists extracted as an anti-malarial artemisinin, the shrub that is indigenous to the country. Hainan Island and Yunnan now remain problem areas.

 

Alarm bells rang recently when signs of tolerance appeared on the Thai-Cambodian border, with the lengthening of the clearance period of parasites, from the initial 48 hours to a few days. This sparked the Containment Project in seven provinces in eastern Thailand and 10 in western Cambodia.

 

The project aims to reduce and eventually eliminate deadly falciparum malaria with a strategy that calls for better prevention, more research, less use of artemisinin monotherapies, and increasing engagement of private providers to provide quality diagnosis and medicines, among others.

 

 

 

 

 

 

Back

Home

 

 

| | | | | |